Incensole is a frankincense-associated cembrenoid diterpene alcohol most useful in the AromaForge archive as an identity and species-marker constituent rather than as a well-validated standalone active. Live sources strongly support its chemical identity and repeated Boswellia occurrence, especially its use as a biomarker in Boswellia papyrifera and as a lower-level marker in some frankincense authentication work. Direct bioactivity literature exists, but it is narrower than the literature for incensole acetate; the clearest accessible constituent-specific signal is a 2016 structure-activity study reporting potent STAT3 inhibition by incensole while NF-kappaB inhibition remained marginal for the native alcohol.
Chemical identity and composition
PubChem identifies incensole as C20H34O2 with InChIKey SSBZLMMXFQMHDP-REDNKFHQSA-N. Public Boswellia papers treat it as one of the characteristic cembrane diterpenes of frankincense resins, but cross-source occurrence varies by species and extraction method. In the accessible 2018 quantification paper, B. papyrifera contained the highest measured incensole levels, B. sacra showed trace amounts, and B. serrata showed none in the tested fractions. In the archive's frankincense oil context, incensole is also used as a low-level authentication marker in lab-distilled B. carterii oil.
Aroma and practical use
- Use the recorded resinous, balsamic, warm, incense-like, resin descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2016 J Nat Prod structure-activity study reported that incensole itself was a potent STAT3 inhibitor, while NF-kappaB inhibition remained marginal for the native alcohols compared with some esterified derivatives.
This is the clearest direct constituent-level mechanistic finding located for incensole, but it is still assay-level evidence rather than human outcome evidence.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2018 quantitative Boswellia study found the highest measured incensole concentration in B. papyrifera resin extracts, trace amounts in B. sacra fractions, and no detected incensole in the tested B. serrata fractions.
This is useful species-context evidence and helps explain why incensole functions well as a marker constituent in frankincense sourcing and authentication work.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2022 authentication study comparing commercial and lab-distilled frankincense oils reported lab-distilled B. carterii reference oils as a benchmark for detecting contamination and adulteration in commercial material.
The abstract does not foreground incensole specifically, but it supports the archive use of low-level frankincense marker constituents in authentication workflows.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No constituent-specific human dermal safety assessment or IFRA-style use limit for isolated incensole was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The accessible Good Scents listing for incensol shows no on-page GHS classification and marks it as not for fragrance or flavor use, but that page is a trade reference rather than a formal toxicology review.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
stat3_inhibition
A 2016 frankincense cembrane structure-activity paper reported that incensole, but not incensole acetate, was a potent STAT3 inhibitor in the assay system used.
This experimental finding does not establish benefit, dose or safety in people using this blend.
weak_native_nf_kappab_inhibition
The same 2016 study described NF-kappaB inhibition as marginal for the two native frankincense alcohols, suggesting that unmodified incensole is not the strongest member of this scaffold for that target.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Most higher-profile frankincense pharmacology papers center on incensole acetate, so incensole-only efficacy claims should stay narrow.
- No verified standalone human safety dossier for isolated incensole was located in this pass.
- Registry and trade references do not always agree on stereochemical mapping or external compound identifiers for incensole.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.